Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Different characteristic phenotypes according to antibody in myasthenia gravis.

Oh SJ, Morgan MB, Lu L, Hatanaka Y, Hemmi S, Young A, Claussen GC.

J Clin Neuromuscul Dis. 2012 Dec;14(2):57-65. doi: 10.1097/CND.0b013e318275197c.

PMID:
23172384
2.

The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.

Nikolic A, Djukic P, Basta I, Hajdukovic Lj, Stojanovic VR, Stevic Z, Nikolic D, Bozic V, Lavrnic S, Lavrnic D.

Clin Neurol Neurosurg. 2013 Apr;115(4):432-7. doi: 10.1016/j.clineuro.2012.06.013. Epub 2012 Jul 6.

PMID:
22770539
3.

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.

Brain. 2003 Oct;126(Pt 10):2304-11. Epub 2003 Jun 23.

PMID:
12821509
4.

MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns.

Stickler DE, Massey JM, Sanders DB.

Clin Neurophysiol. 2005 Sep;116(9):2065-8.

PMID:
16043398
5.

[Ocular involvement in MuSK antibody-positive myasthenia gravis].

Bau V, Hanisch F, Hain B, Zierz S.

Klin Monbl Augenheilkd. 2006 Jan;223(1):81-3. German.

PMID:
16418940
6.

Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.

Wolfe GI, Oh SJ.

Ann N Y Acad Sci. 2008;1132:71-5. doi: 10.1196/annals.1405.005.

PMID:
18567855
7.

Racial differences in myasthenia gravis in Alabama.

Oh SJ, Morgan MB, Lu L, Hatanaka Y, Hemmi S, Young A, Claussen GC.

Muscle Nerve. 2009 Mar;39(3):328-32. doi: 10.1002/mus.21191.

8.

The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.

Feng HY, Wang HY, Liu WB, He XT, Huang X, Luo CM, Li Y.

Neurol Sci. 2013 Jun;34(6):919-24. doi: 10.1007/s10072-012-1159-x. Epub 2012 Jul 25.

PMID:
22829131
9.

Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.

Oh SJ, Hatanaka Y, Hemmi S, Young AM, Scheufele ML, Nations SP, Lu L, Claussen GC, Wolfe GI.

Muscle Nerve. 2006 Apr;33(4):500-4.

PMID:
16392120
10.

Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.

Pasnoor M, Wolfe GI, Nations S, Trivedi J, Barohn RJ, Herbelin L, McVey A, Dimachkie M, Kissel J, Walsh R, Amato A, Mozaffar T, Hungs M, Chui L, Goldstein J, Novella S, Burns T, Phillips L, Claussen G, Young A, Bertorini T, Oh S.

Muscle Nerve. 2010 Mar;41(3):370-4. doi: 10.1002/mus.21533.

PMID:
19882635
11.

Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.

Rostedt Punga A, Ahlqvist K, Bartoccioni E, Scuderi F, Marino M, Suomalainen A, Kalimo H, Stålberg EV.

Clin Neurophysiol. 2006 Jul;117(7):1434-43. Epub 2006 Jun 5.

PMID:
16737845
12.

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A.

Brain. 2006 Jun;129(Pt 6):1481-92. Epub 2006 May 3.

PMID:
16672291
13.

Complete stable remission and autoantibody specificity in myasthenia gravis.

Baggi F, Andreetta F, Maggi L, Confalonieri P, Morandi L, Salerno F, Bernasconi P, Montomoli C, Barberis M, Mantegazza R, Antozzi C.

Neurology. 2013 Jan 8;80(2):188-95. doi: 10.1212/WNL.0b013e31827b907b. Epub 2012 Dec 19.

PMID:
23255823
14.

[Effects of acetylcholinesterase inhibitors on patients with MuSK antibody positive myasthenia gravis].

Konishi T, Kousaka M, Yamakawa K, Matsui M, Ohta K.

Rinsho Shinkeigaku. 2009 Oct;49(10):660-3. Japanese.

PMID:
19999149
15.

Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis.

Muppidi S, Wolfe GI.

Front Neurol Neurosci. 2009;26:109-19. doi: 10.1159/000212372. Epub 2009 Apr 6. Review.

PMID:
19349708
16.

MuSK-antibody-positive myasthenia gravis in a South Asian population.

Chang T, Gunaratne P, Gamage R, Riffsy MT, Vincent A.

J Neurol Sci. 2009 Sep 15;284(1-2):33-5. doi: 10.1016/j.jns.2009.03.020. Epub 2009 Apr 25.

PMID:
19394052
17.

MuSK antibody-positive, seronegative myasthenia gravis in Korea.

Lee JY, Sung JJ, Cho JY, Oh DH, Kim HJ, Park JH, Lee KW, Choi YC, Vincent A.

J Clin Neurosci. 2006 Apr;13(3):353-5. Epub 2006 Mar 20.

PMID:
16546389
18.

Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.

Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, Drachman DB.

Muscle Nerve. 2004 Jul;30(1):55-60.

PMID:
15221879
19.

Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.

Nakata R, Motomura M, Masuda T, Shiraishi H, Tokuda M, Fukuda T, Ando T, Yoshimura T, Tsujihata M, Kawakami A.

Eur J Neurol. 2013 Sep;20(9):1272-6. doi: 10.1111/ene.12169. Epub 2013 May 17.

PMID:
23679930
20.

The features of myasthenia gravis with autoantibodies to MuSK.

Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V, Trikic R, Djukic P, Apostolski S.

J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1099-102.

Supplemental Content

Support Center